Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Description

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Conditions

Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome

Study Overview

Study Details

Study overview

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Condition
Eosinophilic Granulomatosis With Polyangiitis
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California San Diego, San Diego, California, United States, 92122

Denver

National Jewish Health, Denver, Colorado, United States, 80206

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02215

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Cleveland

Cleveland Clinic Foundation, Cleveland, Ohio, United States, 44195

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15260

Salt Lake City

University of Utah, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    University of Pennsylvania,

    Peter A. Merkel, MD, MPH, STUDY_CHAIR, University of Pennsylvania

    Study Record Dates

    2028-12